4A CENSUS (411) MARCH 1, 2021

ICA 1.58 PLEUROPARENCHYMAL FIBROTIC CHANGES, MEDIASTINAL LN. TS W/

1401D ADY /TANTUCO/RCHUA VILLACOTE, ANITA 82/F SGOT 44 SGPT 6 LYTIC OSSEUS CHANGES COMPRESSION DEFROMITIES AND
2/12 CAP HR; HTN; AKI SEC TO DEHYDRATION AND INFECTION ON TOP OF TPAG 57/22/35 ASSOCIATED PARAVERTEBRAL MASSES. POSS POTTS DX NOT R.O
HGB 155 -108-90-99-112 CKD SEC TO HTNSS; HYPERNATREMIA SEC TO POOR ORAL INTAKE FIT NS
ENSURE 200 Q4 HCT 481 -326-262-291-331 S/P APPENDECTOMY S/P OPEN CHOLECSTETOMY >30 YRS S/P CBC KNA K 3/1
30CC FLUSH Q4 PLT 184- 64-177-191-178 PTB(2011) TX 6 MOS >10 YRS RETIC COOMBS LDH NBE
WBC 36.1-12.9-10.2-16.4-11.2 PIPTAZO4//LEVO2//CEFEPIME8//FIXCOM7/MEROPENEM7 HD 3/1
NE 8MG 4CC SEG 97 -89-86-88-86
SBP >130 NA 156 -145- 133-131-133-135 ECG ST (120) LVH 1412 EHAO WANYU CUA 87/F
PNSS 10CC K 3.9 -4.2-4.4 CXR 2/12 PNEUMONIA VS PTB VS CARCINOMATOSIS 2/27 CVA INFARCT R FRONTAL LOBE; AF
CREA 270 – 218-66-72-86-74 AWAITING PEHR PF5ER 2/16 PROGRESSION OF PNEUMONIC WBC 6.6 PIPTAZO2
SIMV 30% BUR14 P SGPT 24 INFILTRATES 2/19 MINIMAL REGRESSION 2/22 PROGRESSION BOOST OPTIMUM HGB 126
10CMH2O U/A NORMAL PNEUMONIC INFILRATES 2/23 PROGRESSION OF PNEUMONIC 200CC Q4 HCT 383 ECG AF
AC 420 16 30 PS 10 TSH 0.21 FT3 2.7 FT4 13.08 INFILTRTAES BPC?  2/26 PROGRESSION OF PNEUMONIC FLUSHING 50CC Q4H PLT 113 CXR MULTICHAMBER ENLARGEMENT BEG BIL CONGESTIVE
CBG BIDAC HBA1c 6.1 INFILTRATES DECR FLUID PD Q8 SEG 87 CHANGES
FA RC 0-2; PC 0; NO PARASITE OVA R CYSTS 2D ECHO: EF 58% CONCENTRIC LV REMODELING WITH NORMAL O2 3LPM NC SGPT 22 CT SCAN ISCHEMIC PROCESS OF VARYING AGES, MOST RECENT IN R
COVID 2/12 NEG BUN 17.8 SEGMENTAL AND GLOBAL SYSTOLIC FUNCTION WITH NORMAL PNSS 60CC NA 145-148 FRONTAL LOBE
TPAG 55/13/42 DIASTOLIC FUNCTION, MITRAL SCLEROSIS WITH MILD MITRAL K 5-4.6 ABG 2/27 PH 7.41 PC02 92.5 O2 95.8 P02 25.9 HCO3 10.4 DFIO2 28%
HRZE 2/24 REGURGITATION; SEVERE CALCIFIC SCLEROSIS WITH AORTIC NE 8MG 25CC/H ICA 1.16 2D E 2/27 EF 48% ECCENTRIC LV HYPERTROPHY WITH HYPOKINESIA;
REGURGITATION, MILD TR, AA, NPAP DOPA 400MG 15CC/H MG 2.82 DIL LA; MITRAL ANNULAR CALCIFICATION WITH SEVERE MITRAL
MAINTAIN BP 120-130 BLOOD CS 2/12 STAPH EPIDERMIDIS SENSITIVE TO CLINDA, CREA 105 -126 REGURGITATION; THICKENED AORTIC VALVE CUSP WITH MILD
LINEZOLID, COTRIMOX, VANCO RESISTANT TO ERYTHRO, PEN G, DNI/DNR FBS 158 AORTIC REGURGITATION ; MOD PULMONARY HYPERTENSION
OXACILLIN LIPID P N 62MMHG
BLOOD CS R FOOT NG X 5 DAYS
SPUTUM AFB D1 NEG D2 NEG CAROTID DOPPLER2/27
SPUTUM GS CS SPUTUM GS g+ COCCI IN SINGLY, PAIRS AND CHAINS 1413 JGO/ETANCU DE GUZMAN, TEOFILO
– FEW , G(-) BACILLI – FEW, FUNGAL SPORES 2/23 SEPTIC SHOCK SEC TO CAP HR
W/HYPHOAMORPHOLOGICALLY RESEMBLING CANDIDA AP., PMN WT 75KG UA BACT FEW PUS 2-3 AZITHRO5(5)//PIPTAZO7(7)
LEUK >25, SQ >10 WBC 25.3-8.7
SPUTUM ACID FAST 2/16 DAY 2 NEG SOFT DM C SAP HGB 143-132 ECG ST 122
BLD CS R FOOT 2/14 NO GROWTH FOR 5 DAYS PNSS 40CC HCT 431-396 CXR 2/22 PNEUMONIC PROCESS B LOWER LOBES 2/6 NSIC OF PNEUMONIC
ABG 2/23 FIO2 30 PO2 70.6 PCO2 38.7 HCO3 25.1 BE 1.3 PH 7.42 NE 8MG 2CC PLT 301-251 INFILTRATES R, MIN REGRESSION LEFT
O2SAT42 O2SAT 9.2 HG 9.3  2/23 PH 2.535 PC02 28.3 P02 354 HCO3 UBP 110 SEG 86-62 ABG 7.41/37.9/62.9/15/91.1/-0.8/23.1
23.8 THGB 8.4 DFIO2 22 PF RATIO 353 1LPM BANDS 11 UA PC 2-3
ETGS G + COCCI IN SINGLY AND PAIRS +, G+ COCCI, FUNGAL SPORES SGPT 22
RESEMBLING CANDIDA FEW, PMN <25 COVID IGG – IGM - NA 136-140
S/P BT 1U PRBC 2/24 2/25 K 3.9-3.7
ETCS 2/23 ACHROMOBACTER S MEROPNEM CREA 136-91
1414 ETAN/SWONG/ ACHAN/ TANTUCO (AMS) RALPH LIM 30/M
CBC NA K CREA TPAG NBE 1/21 TONGUE CA, GASTROSTOMY SITE INFECTION (PSEUDOMONAS), UTI
1402 LDY /STAN ROBERTO DE CASTRO 82/M WBS 9.6-4.1-4-4.2-2.8-3.2-8.6-5.6-6.6 (YEAST)CANDIDEMIA
2/21 WBC 13.9-4.8 CAPMR; COPD BY HISTORY; HCVD; T2DM; HYPONA PEPTAMEN 1KCAL IN HGB 131-99-113-107-99-100-97-87-109 PIPTAZO4// OCTREOTIDE3// FLUCO7/7
HGB 99-95 CEFEPIME 9/LEVOX 4/ MEROPENEM4 250 Q4 HCT 383-287-85—280-288-280-246-321 COTRIMOXAZOLE2//MEROPENEM14//CIPRO7//MICAFUNGIN18//CEFTAZ
3608 HCT 303-254 PNSS 60 PLT 306-184-203-278-296-289-409-361-357 14(14)//LEVOX14(14)//FLUC6(7)
2/18 PLT 245-275 ECG ST 107 COMBIFLEX 1400KCAL K 3.4-3.2-4.4-3.5-3.3-3.4-3.7-3.0-4.3
SEG 92-71 CXR 2/17: PREDEOMINATLY FIBROTIC KOCHS BOT UPPER; LEFT 60CC CREA 68-48-36 -47-45-49-40 CXR 1/24 NO ACTIVE PARENCHYMAL INFILTRATES, BOTH
SD NA 121-113 APICAL PLEURAL THICKENING 2/21 REGRESSION MG 1.92-1.97 -0.81-1.82-0.8-1.90-1.75-1.48 CPSBLUNTED 2/2 NAPI
HL K 4.1-3.9 FOR SPUTUM GS CS; TB GENE XPERT 2/25 PROGRESSION OF NA 130-132130 GASTROSTOMY SITE CS : PSEUDOMONAS AERUGINOSA – LG
D5NSS 10 BUN 6.5 PNEUMONIC INFILTRATES  2/26 PROGRESSION RIGHT LOWER S/P GASTROSTOMY SGOT 28-15-18 SENSITIVE TO AMIKACIN, CEFEPIME, CEFTAZIDINE, CIPROFLOXACIN,
O2 1.5LPM TPAG 60/31/29 SPUTUM GS GM POSITIVE COCCI PAIRS FEW, PMN> 25, SQ < 10 TUBE REMOVAL 2/6 SGPT 35-13-11-15 GENTAMICIN, IMIPENEM, LEVIFLOXACIN, MEROPENEM PIPTAZO
DUAVENTTID HBA1C 6 ABG FIO2 24 7.49/60/33.9/25.7/3.0/89.2/10.8 DFIO2 25.2 URIC 2 WA CT 1/26: NO EVIDENCE OF METS; GASTROSTOMY TUBE IN
SGPT 26 SPUTUM GS NORMAL FLORA EPO 10000 OD PTPA 13.9/1.05/93.0 13/0.98/104 PLACEWITH MINIMAL SURROUNDING AIR DENSITIES IN ABDOMINAL
NAC BID PCT 0.03 SPUTUM CS ALPHA HEMOLYTIC LIGHT GROWTH APTT 24.6 WALL, NO EVIDENCE OF FLUID COLLECTION; MILD SPLEENOMEGALY;
SWAB 2/26 NEG MTB NOT DETECTED TRANEX Q8 UA YEAST + PROSTATIC CONCRETIONS
IGG- IGM- PCT 0.13-0.20 S/P REPOSITIONING OF GASTRO TUBE 1/29
FBS NBE PMGH 2/26 ALP 62 TRACH SECRETION GRAM POSITIVE COCCI, POOR CATCH
BLOOD SC 2/2 SENSITIVE TO FLUCONAZOLE, VORICONAZOLE, AMPHO
1403 ENGO MANUEL, EDUARDO 36/M NOTD IDS B, CASPOFUNGIN, MUCAFUNGIN
2/28 KIDNEY DONOR WOUND GS: NO BACTERIA SEEN, PC FEW
HGB139 WOUND CS 2/5 ACHROMOBATER DENTRIFICANS-ILIGHT GROWTH
NPO HCT 0.41 UA N RESISTANT TO MEROPENEM CIPRO, SENSITIVE TO CEFTAZIMIE
D5LR 120CC/H WBC 9.02 UTZ KIDNEY N GASTROSTOMY TUBE GS 2/6– GRAM NEG BACILLI FEW
SEG 0.38 CXR N IMMUNOTHERAPY 2/9
NO NSAIDS/COX INH PLT 397 TRACHEAL GS CS 2/5: STENOTROPHOMONAS MALTOPHILIA
BUN 5.1 FOR KIDNEY TRANSPLANT 3/1 6AM MODERATE GROWTH; SENSITIVE TO TMP- SMX
CREA 78 BLOOD CS 2/9 RIGHT: NG LEFT: SENSITIVE TO MICAFUNGIN
ALT 10 S/P DAY 4 CHEMO 2/15
BLD CS 2/16 NG 48H
1405 ETINHAY/TINHAY NICOLAS, JR 35/M CT SCAN 2/19 DECR IN SIZE OF RIGHT OROPHARYNGEAL TO
2/25 THROTOXIC HEART DISEASE, PAROX AF; SLIP DISK 2018; HYPOPHARYNGEAL MASS
WBC 5.1 S/P JEJUNOSTOMY TUBE 2/20 EBL <10CC
DAT HGB 132 ECG AF IN RVR S/P BT 2 U PRBC 2/24 2/25
PLR 50CC HCT 402 CXR CILC BLL CARDIOMEGALY W/ PLV
PLT 145 UA 2/25 N 1415 WTDG/ADY/STAN/ECHUA /MLR HELEN TIENG 82/F
DEXA 5MG Q12 SEG 47 2DECHO 2/25 EF 48 DILATED LVD, HYPOKINESIA ; NORMAL RVD W/ 1/29 CAP MR HASCVD AF IN MVR CHF, ELECTROLYTE IMBALANCE,
NA 138 NC, MOD PULMO HPN WBC 15.2-11.7-12.9-11.5-8.4-17.2-14.9-11.2-13.4 HYPONATREMIA
BIDAC K 4.5 WA UTZ 2/26 UPPER BORDER LIVER SIZE SL THICKENED GB WALL, NUTRIBEST 6S IN HGB 140-143-147-145-146-135-140-133-120 AZITH 5//PIPTAZO 10/10// LEVOX13(14)//FLUC7(7)//CEFEPIME7(7)/
CREA 45 NONDILATED DUCTS, SPLENOMEGALY, R RENAL PARENCHYMAL 200CC Q4H HCT 414-421-455-455-430-390-419-386-362 VANCO 2/16 2/19 2/22// CEFIXIME 3
APIXABAN 5 1-0-1 BUIN 3.7 CALCIFICATION, MIN ASCITES HL PLT 264-306-292-250-307-425-477-418-340
SGPT 42 O2 @ 1LPM SEG 82-85-78-76-71-87-85-68-76 ECG 2/2 SINUS RHYTHM WITH SINUS PAUSE POOR R WAVE
ICA 1.29 NA 118-132-135-134-141-136-125-126-129-133 PROGRESSION 2/7 AFM VR 2/9 AF  2/12 AF MVR WITH ISOLATED
MG 1.80 FC 2/9 K 3.7-3.4 -3.1-4.8-3.7-3.7-2.7-4.7-4.3-4.9-5.5-4.6- PVCS  2/15 AF MVR 2/15 AF MVR 2/24 AF RVR
PTPA 19.2/1.47/59 4.1-4.4 CXR 1/28 BILATERAL PNEUMONIA WITH CONGESTIVE CHANGES, LEFT
APTT 34.9/29.6 SALBU TID CREA 55-43-57-95-80-64-72-67 APICAL PLEURAL THICKENING, SUSPICIOUS COVEX DENSITY, RIGHT
FT3 19 -32 FT4 72 -89 TSH 0.01 – 0.01 TPAG 59/35/24 MEDIASTINAL ; PLEURAL EFFUSIOB, BOTH HEMITHORAX  2/2 DEC IN
LP N FBS 112 FC CHANG 2/23 (Q ICA 1.16-1.19 AMT OF FLUID IN R HTX, MIN INC IN FLUIDS, L HTX2/5 FURTHER
FECALYSIS 2/25 -N TUE) MG 1.99- 1.65-0.81-2.07 DECR IN AMT OF FLUID IN BOTH HEMOTHORACES, BETTER
1406 PUY/JCHAN DE DIOS,.ADELMER 37/M TROP I 0.68 DELINEATING THE PNEUMONIC INFILTRTAES 2/09 INC HAZINESS R
2/24 PLEURAL EFFUSION NRIGHT SEC TO CAP MR S/P PTB TX CHANGE FC EVERY PTT 14.7/1.11/86 HTX, DEC IN L HTX; MIN REG PI B UPPER LUNG AREAS  2/12
HGB 120 CEFTRIAXONE6 WEEK FT3 3.01 DECREASE IN THE AMOUNT OF FLUID IN THE RIGHT HEMITHORAX
HL HCT 350 FT4 19.36 WHILE INCREASE LEFT HEMITHORAX  2/13 HEMIDIPHRAGM MORE
PDQ8 PLT 577 ECG NSR NA TSH 1.57 ELEV CROWDING THE RIGHT LUNG MARKING,
WBC 6 CXR 2/20 PLEURAL EFFUSION RIGHT; PNEUMOIA NOT R/O BUN 7.1 SUBPULMONIC/SUBDIAPHRAGMATIC OR PHRENIC NERVE PATHO MUST BE
SEG 69 S/P UTZ GUIDED THORA RIGHT 13090 SEROSANGUINBOUS B HBA1C 5.8 FBS 87 R/O  2/16 MINIMALPNEUMONIC INFILTRATES RIGHT BASE 2/21
K3.8 RESIDUAL 70 2/26 LANOXIN ASSAY 1.59 PROGRESSION
CREA 94 PF CELL COUNT ALL LYMPH PROBNP 16565-21874 CXR 2/25: MIN REGRESSION OF PNM INFIL IN BOTH MID TO LOWER
SGPT 91 PF ACID FAST NEG LP N LUNGS. DEC FLUID IN LEFT CPS.
SLDH 484 PF GS NO BACTERIA APTT 30.3
PTPA 17.2/1.31/68 PF WBC 600 X 10 ALL LYMPHO PCT 0.9 CHEST UTZ 1/29 R 500CC, LEFT 185CC2/5 RIGHT150CC(500) LEFT
TPAG 68/31/37 CHEST CT SCAN RIGHT PLEURAL EFFUSION WITH ASSOCIATED UA PC 5-7, RC 8-10, ALB NEG, SUGAR NEG, 170CC(185) W/PLEURAL THICKENING
PF ALB 28 ATELECTASIS/ CONSOLIDATION, RIGHT APICAL FIBROTIC CHANGES BUDDING YEASTS 2DECHO 1/29 EF 37 DILATED VENTRICULAR DIMENSION WITH
PF PROTEIN 55 XPERT MTB : NEG CYSTATIN C 1.55 EGFR 37 SIGMOID SEPRUM WITH GLOBAL AKINESIA WITH BEST CONTRACTION
PF LDH 599 CHEST UTZ 3/1 AT BASAL INFERIRO AND INFEROLATERAL LEFT VENTRICULAR FREE
EXUDATIVE SPUTUM GENE XPERT-NS WALL WITH DEPRESSED SYSTOLIC FUNCTION. NORMAL RIGHT
2/26 PF CS CELLBLOCK CYTOLOGY VENTRICULAR DIMENSION WITH HYPOCONTRACTILE WALLS .
1407 JTAN/JCHAN BRIONES, FELICITA 71/F DVT 1/29 NEGATIVE
2/28 CAP MR HN T2DM SLE (2012 ON PRED 5 OD) WA CT SCAN 2/5 HYPODENSE FOCI, BILATERAL RENAL
HGB 165 LEVOX 6(7)/ PIPTAZO3 CYST(BOSNIAK1) AND TINY RIGHT RENAL ANGIOLIPOMA
LS LF DM HCT 498 UA 2/9 PH8/PC5-7/RBC8-10/PO42+/BAC2+/ALB(-) 2/15 PH6.5 PC 5-8 RBC
PBNSS 60 PLT 159 ECG SR 3-5 HB TRACE
TIDAC WBC 9.8 CXR2/28 BILATERAL PNEUMONIA WITHJ BRONCHIECTATIC ABG 2/13 FIO2 24% PCO 2 27.7 PO 2 110 HCO3 23.5 BE 2.4 O2 97.9 T HGB 15.9
2L SEG 69 CHANGES BOTH LUNGS DFIO2 16%
I8/E4/30% NA 137 CHEST CT 2/28 CILC R/O INTERSTITIAL FIBROSIS ABG FIO2 21 PH 7.53 PPCO2 25.2 PO2 93.1 HB 15.4 BE 0.3 HCO3 21
K 4.6 SPUTUM GS CS 2/28 DFIO2 17
CREA 63 URINE C/S 2/9 ENTEROCOCCUS FAECIUM >100000 SENSITIVE TO
VANCOMYCIN AND LINEZOLID RESIST AMPICILLIN PEN G
1408 VMAC RICHARD TIU 71/M
UA PH 6.5 PC 8-10 RBC 70-80 SQ 1+ URATES 1+ BAC 1+ ALB 2+ LFAB
2/28 INGUINAL HERNIA
NEG
TPAG 64/39/25
BLD CS LEFT ARM 1 2/16 – NG 48H
PNSS 30CC PTPA 13.1/0.98/102 CXR 2/27 CROWDING OF RIGHT BASAL LUNG MARKINGS, B HILAR
FOR THORA – 2/5 DEFERRED
COMBIFLEX APTT 20.9 FULLNESS
CAROTID DUPLEX 2/24 TOT OBSTRUCTION R PICA, <50% LECA STEN ,
1000KCAL AT ABD XRAY 2/28 ILEUS VS PARTIAL DISTAL OBSTRUCTION
<50 BECA,NVBA
20GTTS THEN TO S/P INGUINALEXPLORATION , LICHENSTEIN HERNIORRHAPHY LEFT,
MRI PLAIN C DWI C MRA 2/27: NO EVIDENCE OF ACUTE INFARCT,
CONSUME PARTIAL OMENTECTOMY 2/28
SMALL CHRONIC INFARCT B BG, MILD TO MOD
CEREBROCEREBELLAR VOL LOSS. ABSENT FLOW RELATED
CBG??
ENHANCEMENT ACROSS RIGHT ICA, MCA SEC TO SEVERE
ATHERSOSCLEROITC DX, HIGH GRADE STENMOSIS INVOLVING
1409 LDY/MUY/DAADDATU/ELIM/STAN BONIFACIO EMBUSCADO 85/M CAVERNOUS LEFT ICA
2/17 PE, BILATERAL SEC TO ?, HASCVD, DMT2 UNCONTROLLED; SP
24 HOLTER MONIT 2/24
WBC 6.0-7.7-6.6-9.3 TOTAL THYROIDECTOMY 15 YRS AGO
1416 ELIM/LTAN PALMES. AMELIA 51/F
SOFT DM DIET HGB 98-100-112-114 PIPTAZO6//CEFEPIME 2/CLINDA 2
2/28
NUTREN DM 200 Q4 HCT 307-314-345-355
WBC 9.3 2DECHO EF 67 NLVD, NRVD , DIL L ATRIUM, NORMAL R ATRIUM
HL PLT 326-347-340-279 ECG ST 105
NPO HGB 121 ABD XRAY ILEUS , MIN FECAL STATSIS
BIDAC SEG 70-63-66-79 CXR PE, BILATERAL 2/18 INC FLUID IN LEFT LOWER HEMOTHORAX
D5LR 20GTTS HCT 376 WA CT PARTIAL SMALL BOWEL OBSTRUCTION VS REFELX ILEUS
O2 1LPM NC NA 128-130-131 DECR IN FLUID IN RIGHT HEMITHORAX 2/23 PROGRESSSION PE
PLT 327
HL CREA 121-115-93-127 LEFT  2/27 INTERVAL DECREASE IN THE LEFT LOWER
SEG 81
OFI 1.2L/DAY K 4.5-4.1-4.7 HEMITHORAX BETTER DELINEATING THE PNEU,ONIC INFILTRTAES
NA 134
CBG Q4 SGPT 25 IN THE LEFT MID TO LOWER LUNG REGION
K4.0
PODEVTA 0-0-14 RETIC 6 CHEST CT SCAN 2/27: PNM LEFT LUNG BPE W/ SUBSEGMETAL
CREA 40
CEA 3.9 PSA 0.61 ATELECTASIS, MIN PERICARDIAL EFF.
ALB GRAD 0.9 TPAG 68/34/34 CHEST UTZ R 800, L 1100
SLDH 1041 ABG UNCOMP METAB ALKA DFIO2 23
PLAN : HBA1C 9.8 S/P UTZ GUIDED THORA RIGHT 750CC TURBID TEA COLORED 1417 LTAN BEJAMIN GO 61/M
RPT CXR DAY AFTER PTPA 16.9/1.29/70 16.1/1.22/75 2D ECHO EF 74 AWMC, PERICARDIAL EFFUSION APPROX 2.5, RA 2/28 HASCVD CAD SEVERE AR, HFREFIN SR FC II
THORA UA PUS 6-8, BAC FEW, SUGAR ++, ALB TRACE AND RV COLLAPSE, IVC COLLAPSINBILITY IS >50% RESPIRATORY
PEG FT4 24 FT3 3.81 TSH 1.84 VARIATION OF TV IS 34% AND MV IS 20% LSLF ECG 3/1
PET CT SCAN PF ALB 25 PF PRO37 PF LDH 681 PF EXUDATIVE NO IVF YET UA 3/1
EXUDATIVE BY LIGHTS FOBT 2/18 NEGATIVE ABG 3/1
NGT 2/27 PF 2/26 RED TURBID 3.4 X 10, WBC 1.8 X 10 S/P PERICARDIOCENTESIS 2/20 CBC FBS SGPT PTPA/APTT CT/BT BLOOD TYPING /NA, K CA MG 3/1
LYMPH 90, NEUTRO 10 PF TB GENE XPERT 2/18 MTB NOT DETECTED 6 U PRBC 6U FWB 6 PLT CNC 6U FRESH FROXEN PLASMA
2DECHO 2/22 EF 75 N LVD AND WT AND AWMC , N RV C NC, N LA C FOR AVR 3/2
LAVI , N ATV MIN TO MEDRATE PERICARDIAL EFFUSION
PIGTAIL ASPI 2/21 78CC 2/22 0CC 1418 ELIM/JDICOGO QUEROL, VICENTE 61/M
EGD 2/24LEFT VOCAL CORDS NO MOVT T/C PARALYSIS, 2/25 T/C LIVER CA, R/O BO
ESOPHAGITIS, GASTRITIS, DUODENAL ULCER WBC 12
PERICADIAL FLUID HISTO: NEG MALIG CELLS NPO HGB 119 CXR 2/25 SOLITARY PULMO NODULE, RIGHT LOWER LUNG
S/P UTZ GUIDED THORACENTESIS LEFT 1L SEROSANGUINOUS PNSS 40 HCT 367 ABD XRAY 2/25 ILEUS VS PARTIAL BOWEL OBSTRUCTION
CHEST CT GROUND GLASS COMBIFLEX 1400 X 36 PLT 366 UTZ MULTILE LIVER MASS
RESIDUAL 268 2/26 PF MTB: NO MTB NGT BSB SEG 80 WAB C TRIPHASIC CT 2/26 RECTOSIGMOID ANNULAR CONSTRICTING
COVID IGG IF M NA 135 MASS WITH PERILESIONAL FAT STRANDING AND PROMINENT
COVID PCR 2/27 K 4.5 PERIRECTAL LYMPH NODES T/C PRIMARY MALIGNANCY
2/26, GENE XPERT, CYTOLOGY AND CELL BLOCK CREA 73 S/P PROCTOSCOPY WITH BIOPSY 2/27 FRIABLE MASS APPROX 15CM
BLOOD CS X 1 SITE 2/27 CEA 702.51 FROM THE ANAL VERGE
TB QUANTIFERON 1/27 PTPA 14.7/1.11/86 S/P STAT COLOSTOMY BAG CREATION 2/27
CBC K CREA NA PROCAL NBE
1410 SCP/WTY/RALBA LO, ANTONIO 61/M 1419C JSEE NARCINOPA, LUCITA 77/F
2/24 CAP MR SUBMANDIBULAR ADENOSQUAMOUS CARCINOMA S/P 2/23 DENGUE FEVER; CAP MR S/P PRE DM OPEN CHOLE (MORE THAN 10
HGB 92 - 97 CHEMO (?) S/P RT (?) HCVD T2DM PROCAL HGB 140-143-133-124-128 YRS)
GB 5S 200 Q4- DRIP HCT 275 -293 CEFEPIME5/ LEVOX5 DAT HCT 42-428-398-369-384 CEFTRI3//AZITHRO3//PIPTAZO6/LEVOX6
FEEDING PLT 280 -209 PLR 40CC PLT 290-17-15-33-45
WBC 5.8 -7.3 ECG NSR BIDAC SEG 72-44-26-35-36 ECG LAE, NSSTWC
PNSS 1l + 20KCL 40 SEG 86 – 89 CXR INC FLUID IN RLHTX, PROG PNM W/ CONSOLIDATION AND WBC 11.2-4.8-5.9-8.7-8.2 CXR 2/23 CILC IPP 2/27 PROGRESSION LLL, NEW INFILTRTAES RLL
1LPM NODULES BL  2/27 DECEREASE FLUID IN RLL; PROGRESSION BOTH NA 137-136 ABG 7.46/38/119/26.9/35/98.9/14.6 DFIO 2 18.59
NA 121 LUNGS WITH CONSOLIDATION CREA 76—3.4 UA PC 3-5 BAC FEW
TIDAC K 3.3 ABG 2/24 K 4.19 DVT 2/24 NEG
CREA 58 PTPA 13.5/1.02/98 BLOOD CS 2/23 NG
PLAN CETUXIMAB TPAG 56/29/27 APTT 27.5/29.6 S/P 5U PLT CONCENTRATE
TSH 24.73 HBA1C 2/27 DENGUE NS + IGG+ IGM - SPUTUM GSCS-NS
FT4 10.68 TPAG NBE
1411 FONG/STAN/AKOH PANLILIO, LETICIA 68/F CBC 3/1
(3605) ACUTE PULMONARY CONGESTION; ESRD SEC TO HTNSS VS DKD ON 1421 MONGO/WALBA/STAN/LUKOH/YUTIAO SHI MING LIANG 52/M
2/23 WBC 10.9 -7.2 HD (MWF);PTB 2/18 ANEMIA SEC TO UGIB SEC TO PUD S/P EGD S/P COLONOSCOPY;
HGB 96 -70 RECURRENT PLEURAL EFFUSION S/P TGHORA RIGHT (2/18) WBC 26.6-9.7-11-9.3-12.9-11.4 METAB ENCEPH SEC TO HYPONATREMIA; HPN; T2DM; S/P
LSLF HCT 0.31-226 CEFEPIME7/HRZE NPO EXCEPT MEDS HGB 35-56-99-95-107-100 APPENDECTOMY (>10 YRS AGO); S/P CVA BLEED WITH RIGHT SIDED
3LPM PLT 146-118 COMBIFLEX 70 (30 PLT 809-589-220-384-488 RESIDUAL
HL SEG 61-69 ECG WHILE ON BT) SEG 78-89-85-89-86-84 PIPTAZO5//MEROP8/ METRO11/FLUC8
BIDAC CREA 180 CXR DECREASE IN AMT OF FLUID LEFT; PROGRESSION OF PNSS 10 CREA 146-105-75-92
PD Q12 NA 141 INFILTRATES IN BOTH LUNGS NOREPI 8 MG X 2 BUN 8 CXR CILC, RLL
K 3.8-3.0 ABG 2/23 PH 7.18 PC02 70.7 P02 163 HCO3 26.1 O2 SAT 99.4 DFIO2 28% CC/HR NA 123-136-137-135-137-130 ECG ST
LANTUS 10 OD IPOS 1.06 S/P HD 2/23 2/24 2/25 2/26 , 2/27 K 4.8-4.0-3.8-3.5-4.2-4 ABD XRAY : ILEUS 52
MG 0.90 N CHEST CT 2/27 : BPE; LOCULATION RIGHT , BILAT IVF SGPT 20 WACT CONSIDERAN EXTRAINTESTINAL SOFT TISSUE MASS W
 4A CENSUS (411) MARCH 1, 2021
RIGHT ARM ICA 1.14 INFILTRATIONOF THE ADJACENTSMALL BOWELSAND POSSIBLE
COMBIFLEX + MG 0.93 FISTULOUS TRACT
40MEQS KCAL 60CC SI 2.2 S/P EGD COLON, SIGMOID ULCER PROB FROM EXTRINSIC MASS VS
PLR+ 40MEQS KCL ICA 1.14 STERCORAL ULCER, COLONIC POLYP S/P ENDOLOOP FF BY SNARE
20CC + NACL 1 VIAL MG 2.26 POLYPECTOMY, INT HEMORRHOIDS, ESOPHATIGITS IA GR D
OXYNORM 7CC/H TO FERRITIN 160.7 S/P 4 UNITS FFP
CONSUME TPAG 50/17/33  51/18/33 S/P 2 UNITS PRBC 2/16
CT 10MIN S/P 3RD UNIT PRBC 2/17
BT 2MIN S/P 4TH UNIT PRBC 2/18 5TH U PRBC 2/18
CBG Q6 PTPA 13.9/1.05/93 CRANIAL MRI 2/19 MULT ACUTE INFARCT B FRONTAL AND PARIETAL
PODEVTA 0-0-8 CEA 1.17 AND LEFT OCCP WJITE MATER. OLD HEMORRHAGIC INFARCT IN LEFT
O2 2LPM FIT POSITIVE EXT CAPSULE. SEC CHRONIC LAC INFARCT BG CR, OLD MICRO
FA RBC 3-5, PUS 0-1 YEASTS FEW, BLACK HEMORRHAGE .
AMILOPRIDE UA PUS 0-2. RBC 0-2. BAC RARE AU +++ S/P EMERGENCY EXLAP 1ST CASE 2/20
AM TOT BIL 6.3 S/P 4U PRBC 2U FFP1U FWB 2/20 FFP 2/22
ISULORIDE I BIL 3.5 S/P EXLAP 2/20 EBL 3L
D BIL 2.8 S/P 1U PRBC 2/21 AM
HISTOPATH 2/25: TCEL LYMPHOPROLATIVE DISORDER, LYMPHONA,
NEUROENDOCRINE TUMOR
HISTOPATH 2/24 RETROPERITONEAL MASS T CEL
LYPMPHOPROLIFERATIVE DISORDER, RETROPERITONEAL MASS
LYMPHOMA OR NNEUROENDOCRINE TUMOR
IMMUNOHISTOCHEMICAL STAINING 2/25: T CELL
LYMPHOPROLIFERATIVE DISORDER

1422 LTINHAY/ECHUA SERRANO, SENITH 24/F

2/24 CHF SEC TO THYROTOXICOSIS; ANEMIA SEC TO CHRONIC DISEASE
HGB 70 -80-93 VS AUB; G1 P0 15 WKS AOG T/C NEPHROTUC SYNDROME, RO LUPUS
LF HCT 0.211 -236-269 NEPHRITIS
HL PLT 177 -155-144 ATB?
RA WBC 3.5 -2.5-3.2 CEFTRI5(5)//UNASYN0
LASIX 40 Q8 SEG 49 –38-35
LYMPH 39 ECG ST
TIDAC SGPT 13 CXR BIATERAL IPP, GRANULOMA VS LN V INFECTIOUS, CARDIOMEG
NA 134 -131 2DE 2/24 EF 71 NORMAL RVD, DIL LEFT ATRIUM, MILD PERICARDIAL
PRED 30 TID K 4.7 -4.3 EFFUSION
CREA 58 -69 VAGINAL DISCHARGE 2/25 : G + COCCI (3+), G – BACILLI (3+) PUS –
MG 1.36 FEW
LP N URINE RBC MORPH 2/25: EUMORPHIC 90%, DYSMORPHIC 10%
TOTAL CHOLE 6.44 H RANDOM URINE PROTEIN: 763
TPAG 39/7/32 RANDOM URIN NE CREA70.69
FT3 4.17 BT 1 U PRBC 2/25 2/26
FT4 14.25 WAB UTS 2/26 SLIUP 14WKS AOG N KIDNEYS
TSH 0.01 24 HR URINE CHON 6446.7
HBSAG ANTI HCV NR URINE CS 2/25
C3 244 C3 ANA 2/26
CBC NA K ICA MG NBE

1423 MPEREZ/AKOH MERCADO, LEONCADIA 90/F

2/22 ACUTE PULMONARY CONGESTION SEC TO CHF, HCVD, TYPE 2DM
WBC 8.7-14.7 PIPTAZO8
NUTREN DM 200 Q4 HGB 113-117
HCT 353 CXR 2/24 ET 3CM FROM CARINA
AC 480 20 30 PLT 322- 332 ECG SR
ONGOING TPIECE SEG 75-85 2DECHO EF 74 CONC LV, MILD TR, PILD PULMO HTN 2/23
CPAP 5CMH2O FIO2 NA 119-125-138 UA PH 5 PC 8-10 RBC 4-6 SQ 2+URATE 1+ BAC 2+ ALB 2+
40% K 4.9-3.3 SFA ILEUS
CREA 80 ABG PH 7.19 CO2 75 O2 185 BE1.6 NAHCO3 27.8 HGB 98.9 DFIO2 21
PNSS 40CC WITHTROP I 0.01 2/23 7.121/93.3/ 61.4/ 29.1/88.6  2/23 7.246/63.2/400/10.8/26.5/-1.2 
20MEQS KCL CK MB 58.8 2/25 7.40/56.9/92.6/13/8.8/35 /  7.39/62/117/37.1/10.5/98/11.6
SGPT 33 ET GS CS 2/23
TIDAC HBA1C 6.7
TPAG 68/38/30
PTPA 12.8/0.96/106
1424 ETAN ASPRER WILHEFORTES 58/F
2/22 MALIGNANT NEOPLASM OF BREAST LEFT, WITH LUNG BONE LIVER
WBC 21 -12.9 METS ST 4 T4N2 BM1
HGB 146-153 COAMOX5
FULL DIET HCT 464- 448
1LPM PLT 209-161 CXR PLEURAL EFFUSION LEFT
SEG 52- 81 CHESTPLEURAL EFFUSION LEFT 800 RIGHT 0S/P THORA LEFT 1L
MGH TPAG 67/27/40  66/25/41 SANGUINOUS
SGOT 378 PF ACID FAST –
SGPT 180 PF HISTOPATH NEGATIVE FOR MALIGNANT CELLS
CREA 33-86 PF GS –NO GROWTH AFTER 3 DAYS
K 3.7 CXR 2/25: INTERVAL DECREASE OF FLUID IN LEFT HEMITHORAX AS
TBIL 279 WEL AS RIGHT CPS. MIN PROG OF INFIL IN RIGHT LUNG.
I BIL 124
D BIL 154 ICA K NBE
SLDH 2203 ER PR HER2NEU OF BIOPSY LAST JANUARY
PTPA 15.2/1.15/82> 19.3/1.47/58
APTT 27.6/29.6> 30.5/29.6
ICA 1.31
TRANSUDATIVE BY LIGHTS
1425 WTDG/ MLR/MCO ROSARIO LOPEZ 65/F
65 KG CVA BLEED, HTN, T2DM
WBC 9.4-15.2-12.9 CEFTRIAXONE 9// CEFIXIME4
NICU1 HGB 140-146-143
2/15 PLT 214-235-173 ECG SB 53 BPM 2/20 ST
SEG 64-81-69 CXR 2/15 CONSIDER BEGINNING IPP BLL, R MEDIASTINAL FULLNESS,
PEPTAMEN 1620KCAL NA 138-139-145-162-167-161-155-144 HAZY L CPS MIN FLUID VS INFILTRATES -> 2/19 REGRESSION OF
100G CHON K 3.7-3.9-4.2-3-3.4-4.2-4.3-3.9 INFILTRATES  2/25 REGRESSION
230CCQ4, 50CC CREA 53-45-50-71-52-53-63-50
WATER FLUSHING BUN 7
POST FEEDING 50CC SGPT 25
WATER IN BED APTT 25.5/29.6 CRANIAL CT 2/15 ACUTE ICH W/ SIGNS OF EARLIER BLEED: 26.4CC W/
FLUSHING HBA1C 9.6 EPICENTER IN L CAPSULOGANGLIONIC AREA W/ FLUID TO FLUID
CBG Q4 UA P 0-1 R 1-2 BACT FEW SUG 3+ > PUS 3- LEVEL W/ PERILESIONAL EDEMA, COMPRESSION OF L LAT
4/RBC 60-80/SQ FEW/AMORPH FEW/BAC VENTRICLE W/ SHIFT OF MIDLINE STRUCTURES/ SUBFALCINE
PLR + 20MEQS KCL X FEW/ALB NEGATIVE/ SUGAR +++ HERNIATION TO THE R APPROX 0.3CM
10CC TC 5.76/TG 1.34/HDL 1.26/LDL 3.89/VLDL
HL 0.61/HDL RATIO 4.57 2DECHO 74% CONCENTRIV LV REMODELLING SL DIL LA TH AORTIC
MBP 120-150 FBS 169 CUSPS WITH DISCRETE NODULE AT THE TIP OF LCC WITHOUT ROM,
MILD AR, ST N TV AND PV MILD TR, MILD PR, NO THROMBUS,
MANNITOL 75CC Q6 PERICARDIAL EFFUSION, MILD PULMO HTN
AMLO 10 OD
CANDES 8 OD CAROTID DUPLEX 2/16 CAROTID ARTERY DISEASE WITH <50%
CLONIDINE 75 BID STENOSES OF THE RIGHT ICA WITH TYPE III PLAQUE MORPHOLOGY
CARVEDILOL 12.5 AT THE BULB AND DISTAL ICA <50% STENOSES OF THE LEFT
BID PROXIMAL CCA AND BILATERAL ECA. NORMAL BILATERAL
VERTEBRAL ARTERY FLOW
PODEVTA 48U
NOVORAPID 20U UA 2/29 PH5 PC 3-4 RBC 60-80 ALB (-) URATES FEW SQ FEW BAC FEW
SUGAR 3+
D14 POST BLEED CREA NA K 3/2

MGH 3/2